vs

Side-by-side financial comparison of Expedia Group (EXPE) and Zimmer Biomet (ZBH). Click either name above to swap in a different company.

Expedia Group is the larger business by last-quarter revenue ($3.5B vs $2.1B, roughly 1.7× Zimmer Biomet). Zimmer Biomet runs the higher net margin — 11.4% vs 5.8%, a 5.6% gap on every dollar of revenue. On growth, Expedia Group posted the faster year-over-year revenue change (18.7% vs 9.3%). Over the past eight quarters, Zimmer Biomet's revenue compounded faster (3.7% CAGR vs -0.2%).

Expedia Inc. is an online travel agency owned by Expedia Group, based in Seattle. The website and mobile app can be used to book airline tickets, hotel reservations, car rentals, cruise ships, activities and vacation rentals. Expedia.com was launched on October 22, 1996 by Microsoft.

Zimmer Biomet Holdings, Inc. is a publicly traded American medical device company. It was founded in 1927 to produce aluminum splints. The firm is headquartered in Warsaw, Indiana, where it is part of the medical devices business cluster.

EXPE vs ZBH — Head-to-Head

Bigger by revenue
EXPE
EXPE
1.7× larger
EXPE
$3.5B
$2.1B
ZBH
Growing faster (revenue YoY)
EXPE
EXPE
+9.4% gap
EXPE
18.7%
9.3%
ZBH
Higher net margin
ZBH
ZBH
5.6% more per $
ZBH
11.4%
5.8%
EXPE
Faster 2-yr revenue CAGR
ZBH
ZBH
Annualised
ZBH
3.7%
-0.2%
EXPE

Income Statement — Q1 FY2026 vs Q1 FY2026

Metric
EXPE
EXPE
ZBH
ZBH
Revenue
$3.5B
$2.1B
Net Profit
$205.0M
$238.3M
Gross Margin
64.6%
Operating Margin
11.8%
17.9%
Net Margin
5.8%
11.4%
Revenue YoY
18.7%
9.3%
Net Profit YoY
202.5%
30.5%
EPS (diluted)
$1.56
$1.22

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
EXPE
EXPE
ZBH
ZBH
Q1 26
$3.5B
$2.1B
Q4 25
$3.5B
$2.2B
Q3 25
$4.4B
$2.0B
Q2 25
$3.8B
$2.1B
Q1 25
$3.0B
$1.9B
Q4 24
$3.2B
$2.0B
Q3 24
$4.1B
$1.8B
Q2 24
$3.6B
$1.9B
Net Profit
EXPE
EXPE
ZBH
ZBH
Q1 26
$205.0M
$238.3M
Q4 25
$205.0M
$139.4M
Q3 25
$959.0M
$230.9M
Q2 25
$330.0M
$152.8M
Q1 25
$-200.0M
$182.0M
Q4 24
$299.0M
$239.5M
Q3 24
$684.0M
$249.1M
Q2 24
$386.0M
$242.8M
Gross Margin
EXPE
EXPE
ZBH
ZBH
Q1 26
64.6%
Q4 25
64.7%
Q3 25
72.1%
Q2 25
71.5%
Q1 25
71.2%
Q4 24
71.0%
Q3 24
70.5%
Q2 24
71.5%
Operating Margin
EXPE
EXPE
ZBH
ZBH
Q1 26
11.8%
17.9%
Q4 25
11.8%
6.9%
Q3 25
23.5%
17.6%
Q2 25
12.8%
14.4%
Q1 25
-2.3%
15.3%
Q4 24
6.8%
19.2%
Q3 24
18.8%
15.3%
Q2 24
12.7%
18.1%
Net Margin
EXPE
EXPE
ZBH
ZBH
Q1 26
5.8%
11.4%
Q4 25
5.8%
6.2%
Q3 25
21.7%
11.5%
Q2 25
8.7%
7.4%
Q1 25
-6.7%
9.5%
Q4 24
9.4%
11.8%
Q3 24
16.8%
13.7%
Q2 24
10.8%
12.5%
EPS (diluted)
EXPE
EXPE
ZBH
ZBH
Q1 26
$1.56
$1.22
Q4 25
$1.56
$0.71
Q3 25
$7.33
$1.16
Q2 25
$2.48
$0.77
Q1 25
$-1.56
$0.91
Q4 24
$2.10
$1.18
Q3 24
$5.04
$1.23
Q2 24
$2.80
$1.18

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
EXPE
EXPE
ZBH
ZBH
Cash + ST InvestmentsLiquidity on hand
$5.7B
$424.2M
Total DebtLower is stronger
$6.2B
$7.5B
Stockholders' EquityBook value
$1.3B
$12.7B
Total Assets
$24.5B
$22.7B
Debt / EquityLower = less leverage
4.80×
0.59×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
EXPE
EXPE
ZBH
ZBH
Q1 26
$5.7B
$424.2M
Q4 25
$5.7B
$591.9M
Q3 25
$6.2B
$1.3B
Q2 25
$6.7B
$556.9M
Q1 25
$6.1B
$1.4B
Q4 24
$4.5B
$525.5M
Q3 24
$4.9B
$569.0M
Q2 24
$6.3B
$420.1M
Total Debt
EXPE
EXPE
ZBH
ZBH
Q1 26
$6.2B
$7.5B
Q4 25
$6.2B
Q3 25
$6.2B
Q2 25
$6.2B
Q1 25
$6.2B
Q4 24
$6.3B
Q3 24
$6.3B
Q2 24
$6.3B
Stockholders' Equity
EXPE
EXPE
ZBH
ZBH
Q1 26
$1.3B
$12.7B
Q4 25
$1.3B
$12.7B
Q3 25
$1.3B
$12.8B
Q2 25
$836.0M
$12.5B
Q1 25
$1.1B
$12.4B
Q4 24
$1.6B
$12.5B
Q3 24
$1.3B
$12.4B
Q2 24
$889.0M
$12.7B
Total Assets
EXPE
EXPE
ZBH
ZBH
Q1 26
$24.5B
$22.7B
Q4 25
$24.5B
$23.1B
Q3 25
$25.1B
$23.5B
Q2 25
$27.0B
$22.9B
Q1 25
$26.1B
$22.2B
Q4 24
$22.4B
$21.4B
Q3 24
$23.4B
$21.7B
Q2 24
$25.9B
$21.5B
Debt / Equity
EXPE
EXPE
ZBH
ZBH
Q1 26
4.80×
0.59×
Q4 25
4.80×
Q3 25
4.65×
Q2 25
7.43×
Q1 25
5.79×
Q4 24
4.02×
Q3 24
4.74×
Q2 24
7.04×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
EXPE
EXPE
ZBH
ZBH
Operating Cash FlowLast quarter
$359.4M
Free Cash FlowOCF − Capex
$245.9M
FCF MarginFCF / Revenue
11.8%
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
1.51×
TTM Free Cash FlowTrailing 4 quarters
$1.4B

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
EXPE
EXPE
ZBH
ZBH
Q1 26
$359.4M
Q4 25
$304.0M
$517.4M
Q3 25
$-497.0M
$418.7M
Q2 25
$1.1B
$378.2M
Q1 25
$3.0B
$382.8M
Q4 24
$198.0M
$506.3M
Q3 24
$-1.5B
$395.7M
Q2 24
$1.5B
$369.4M
Free Cash Flow
EXPE
EXPE
ZBH
ZBH
Q1 26
$245.9M
Q4 25
$119.0M
$442.6M
Q3 25
$-686.0M
$363.7M
Q2 25
$921.0M
$328.1M
Q1 25
$2.8B
$338.2M
Q4 24
$7.0M
$454.8M
Q3 24
$-1.7B
$351.2M
Q2 24
$1.3B
$316.7M
FCF Margin
EXPE
EXPE
ZBH
ZBH
Q1 26
11.8%
Q4 25
3.4%
19.7%
Q3 25
-15.5%
18.2%
Q2 25
24.3%
15.8%
Q1 25
92.2%
17.7%
Q4 24
0.2%
22.5%
Q3 24
-41.6%
19.3%
Q2 24
36.7%
16.3%
Capex Intensity
EXPE
EXPE
ZBH
ZBH
Q1 26
Q4 25
5.2%
3.3%
Q3 25
4.3%
2.7%
Q2 25
5.3%
2.4%
Q1 25
6.6%
2.3%
Q4 24
6.0%
2.5%
Q3 24
4.8%
2.4%
Q2 24
5.5%
2.7%
Cash Conversion
EXPE
EXPE
ZBH
ZBH
Q1 26
1.51×
Q4 25
1.48×
3.71×
Q3 25
-0.52×
1.81×
Q2 25
3.40×
2.48×
Q1 25
2.10×
Q4 24
0.66×
2.11×
Q3 24
-2.18×
1.59×
Q2 24
3.89×
1.52×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons